A systematic review demonstrates that semaglutide can cause hypoglycemia, but liraglutide is associated with a higher incidence of serious side effects
Tirzepatide , a dual GLP-1/GIP receptor agonist, has been approved by NICE for type 2 diabetes management
Weve seen patients on semaglutide for years, and it still works just as well as it did on day one. What expanded GLP-1 weight-loss treatment options mean for patients With pill-form semaglutide entering the market, physicians expect increased competition, which should mean not just lower costs, but also greater normalization of medically supervised weight-loss solutions
Sustainable weight loss should focus on fat reduction rather than muscle depletion, and a combination of high-quality protein sources and an active lifestyle provides the foundation for long-term success.
It facilitates the transport of long-chain fatty acids into the mitochondria (the energy-producing parts of cells)